Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus
- 1 February 2010
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (2) , 146-151
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Factors Associated with Overall and Attributable Mortality in Invasive AspergillosisClinical Infectious Diseases, 2008
- Posaconazole in the management of refractory invasive fungal infectionsTherapeutics and Clinical Risk Management, 2008
- Invasive Aspergillosis in Patients with Acute Leukemia: Update on Morbidity and Mortality--SEIFEM-C ReportClinical Infectious Diseases, 2007
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997Clinical Infectious Diseases, 2001
- Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Disseminated Candidiasis and AspergillosisAntimicrobial Agents and Chemotherapy, 2000
- In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important FungiAntimicrobial Agents and Chemotherapy, 2000
- Therapeutic Outcome in Invasive AspergillosisClinical Infectious Diseases, 1996
- Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalJournal of Infection, 1996